Aducanumab: A Deep Dive into BIIB037 and its Impact This drug, previously known as BIIB037, represents a complex attempt to treat mild Alzheimer's condition. Designed by Biogen, aducanumab works by clearing amyloid https://www.targetmol.com/compound/aducanumab